首页> 外文OA文献 >P347 Vedolizumab as first line biologic therapy in elderly patients with contraindications against anti-TNF therapy - A real-world nationwide cohort of patients with inflammatory bowel diseases

【2h】

P347 Vedolizumab as first line biologic therapy in elderly patients with contraindications against anti-TNF therapy - A real-world nationwide cohort of patients with inflammatory bowel diseases

机译：P347 vedolizumab作为老年人生物治疗禁忌患者反对抗TNF疗法 - 一个真正的全球全球全国炎症肠疾病患者

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
M Attauabi; C Höglund; J Fassov; K B Pedersen; H Bansholm Hansen; S Wildt; M Dam Jensen; A Neumann; C Lind; H Albæk Jacobsen; A M Popa; J Kjeldsen; N Pedersen; A Molazahi; K Haderselv; C Aalykke; T Knudsen; W Cebula; P Munkholm; F Bendtsen; J B Seidelin; B Johan;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study [J] . Guerra Ivan, Perez-Jeldres Tamara, Iborra Marisa, Inflammatory bowel diseases . 2016,第4期

机译：炎症肠病患者抗TNF治疗患者患者患者的发病率，临床特征和管理：全国队列队列研究
2. Dual biological therapy with anti-TNF, vedolizumab or ustekinumab in inflammatory bowel disease: a systematic review with pool analysis [J] . Ribaldone Davide Giuseppe, Pellicano Rinaldo, Vernero Marta, Scandinavian journal of gastroenterology. . 2019,第4期

机译：抗TNF，VEDOLIZUMAB或USTEKUMAB在炎症性肠病中的双生物治疗：通过池分析进行系统审查
3. Dual biological therapy with anti-TNF, vedolizumab or ustekinumab in inflammatory bowel disease: a systematic review with pool analysis [J] . Davide Giuseppe Ribaldone, Rinaldo Pellicano, Marta Vernero, Scandinavian journal of gastroenterology. . 2019,第1a12期

机译：抗TNF，VEDOLIZUMAB或USTEKUMAB在炎症性肠病中的双生物治疗：通过池分析进行系统审查
4. Using Electromagnetic Microwave Field Combined With Laserotherapy in Postoperative Period of Patients With Purulent-Inflammatory Diseases of the Hand in Outpatient Clinic [C] . L. Rabenok, V. Grimalsky, D. Juarez-R. Mexican Symposium on Medical Physics . 2008

机译：使用电磁微波场与激光疗法联合在术后诊所的尿液炎症疾病患者术后疗法
5. Oxidation Status as a Predictor of Disease Activity and Response to Therapy in Pediatric Patients with Inflammatory Bowel Disease [D] . Ajithkumar, Aravindh K. 2020

机译：氧化地位作为疾病活动的预测因素，对炎症性肠病儿科患者的疗法响应
6. Comparative Effectiveness of Vedolizumab vs. Infliximab Induction Therapy in Ulcerative Colitis: Experience of a Real-World Cohort at a Tertiary Inflammatory Bowel Disease Center [O] . Chaitanya Allamneni, Krishna Venkata, Huifeng Yun, 2018

机译：Vedolizumab与Infliximab诱导疗法在溃疡性结肠炎中的比较疗效：第三级炎症性肠病中心的真实队列研究
7. P560 Clinical outcomes of vedolizumab maintenance treatment for Korean patients with inflammatory bowel disease who failed anti-TNF therapy: A KASID prospective multicenter cohort study [O] . K Oh, J Kim, N Kim, 2021

机译：P560 Vedolizumab患者对韩国炎症性肠病患者的临床结果，抗TNF治疗失败：KASID前瞻性多中心队列研究

P347 Vedolizumab as first line biologic therapy in elderly patients with contraindications against anti-TNF therapy - A real-world nationwide cohort of patients with inflammatory bowel diseases

著录项

相似文献

相关主题

期刊订阅